Ygot, Estrella L.
HRN: 24-50-56 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2025
CEFTRIAXONE 1G (VIAL)
08/28/2025
09/03/2025
IVTT
2g
Once A Day
Cholecystitis
Checking Initial Appropriateness
08/28/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/28/2025
09/03/2025
IVTT
500mg
Every 8hrs
Cholecystitis
Checking Initial Appropriateness
09/06/2025
CEFIXIME 200MG (CAP)
09/06/2025
09/12/2025
PO
200mg
BID
Massive Ascites
Checking Initial Appropriateness
12/30/2025
CO-AMOXICLAV 625MG (TAB)
12/30/2025
01/06/2026
PO
500
Q12
Cellulitis
Checking Final Appropriateness
12/30/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/30/2025
01/05/2026
IV
2.5
Q6
Cellulitis
Checking Final Appropriateness
12/30/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/30/2025
01/05/2026
IV
1.5
Q6
Cellulitis
Checking Final Appropriateness